DK163989C - Analogifremgangsmaade til fremstilling af beta-adrenergisk blokerende forbindelser og farmaceutisk acceptable salte deraf - Google Patents

Analogifremgangsmaade til fremstilling af beta-adrenergisk blokerende forbindelser og farmaceutisk acceptable salte deraf

Info

Publication number
DK163989C
DK163989C DK336682A DK336682A DK163989C DK 163989 C DK163989 C DK 163989C DK 336682 A DK336682 A DK 336682A DK 336682 A DK336682 A DK 336682A DK 163989 C DK163989 C DK 163989C
Authority
DK
Denmark
Prior art keywords
addrenergic
analogue
beta
preparation
acceptable salts
Prior art date
Application number
DK336682A
Other languages
English (en)
Other versions
DK336682A (da
DK163989B (da
Inventor
Sheung-Tsam Kam
Paul W Erhardt
Robert J Borgman
John P O'donnell
Original Assignee
Du Pont Merck Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont Merck Pharma filed Critical Du Pont Merck Pharma
Publication of DK336682A publication Critical patent/DK336682A/da
Publication of DK163989B publication Critical patent/DK163989B/da
Application granted granted Critical
Publication of DK163989C publication Critical patent/DK163989C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/08Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions not involving the formation of amino groups, hydroxy groups or etherified or esterified hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK336682A 1980-11-28 1982-07-28 Analogifremgangsmaade til fremstilling af beta-adrenergisk blokerende forbindelser og farmaceutisk acceptable salte deraf DK163989C (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US06/211,341 US4405642A (en) 1980-11-28 1980-11-28 Method for treatment or prophylaxis of cardiac disorders
US21134180 1980-11-28
US8101517 1981-11-16
PCT/US1981/001517 WO1982001868A1 (en) 1980-11-28 1981-11-16 Method for treatment or prophylaxis of cardiac disorders

Publications (3)

Publication Number Publication Date
DK336682A DK336682A (da) 1982-07-28
DK163989B DK163989B (da) 1992-04-27
DK163989C true DK163989C (da) 1992-09-21

Family

ID=22786525

Family Applications (1)

Application Number Title Priority Date Filing Date
DK336682A DK163989C (da) 1980-11-28 1982-07-28 Analogifremgangsmaade til fremstilling af beta-adrenergisk blokerende forbindelser og farmaceutisk acceptable salte deraf

Country Status (13)

Country Link
US (1) US4405642A (da)
EP (2) EP0053436B1 (da)
JP (1) JPS57502125A (da)
KR (1) KR880001828B1 (da)
AU (1) AU547994B2 (da)
CA (1) CA1180344A (da)
DK (1) DK163989C (da)
GR (1) GR76922B (da)
IL (1) IL64344A (da)
NZ (1) NZ198871A (da)
PH (1) PH18954A (da)
WO (1) WO1982001868A1 (da)
ZA (1) ZA817891B (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4604481A (en) * 1980-11-28 1986-08-05 American Hospital Supply Corporation Compounds for treatment or prophylaxis of cardiac disorders
US4405642A (en) * 1980-11-28 1983-09-20 American Hospital Supply Corporation Method for treatment or prophylaxis of cardiac disorders
US4402974A (en) * 1981-06-23 1983-09-06 American Hospital Supply Corporation Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents
US4798892A (en) * 1981-11-12 1989-01-17 E. I. Du Pont De Nemours And Company 2-hydroxypropylamine heteroaryl ester derivatives
US4582855A (en) * 1981-11-12 1986-04-15 American Hospital Supply Corporation Aromatic and esters of hydroxypropylamines
US4579867A (en) * 1984-04-09 1986-04-01 American Hospital Supply Corporation Stable pharmaceutical compositions of short-acting β-adrenergic receptor blocking agents
DE3705384A1 (de) * 1987-02-20 1988-09-01 Goedecke Ag 2-propylamin-derivate, verfahren zu deren herstellung sowie deren verwendung
US4897417A (en) * 1988-12-15 1990-01-30 E. I. Du Pont De Nemours & Co. Prodrugs of 3,4-hydroxy benzoyloxypropanolamines
US4966914A (en) * 1988-12-15 1990-10-30 E. I. Du Pont De Nemours And Company Oculoselective beta-blockers as antiglaucoma agents
US6750238B1 (en) 2000-05-12 2004-06-15 The University Of Toledo Aralkyl ester soft drugs
US7049326B2 (en) * 2000-05-12 2006-05-23 The University Of Toledo Method and compositions for temporarily incapacitating subjects
US6756047B2 (en) 2000-05-12 2004-06-29 The University Of Toledo Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL75127C (da) * 1943-10-05
NL300886A (da) * 1962-11-23
NL301580A (da) * 1962-12-11
US3254112A (en) * 1963-05-16 1966-05-31 Philips Corp Substituted tertiary amino compounds having valuable pharmacological properties
GB1177407A (en) * 1967-05-12 1970-01-14 Science Union & Cie New Benzoic Acid Esters
DE1643262C3 (de) * 1967-12-13 1975-06-26 C.H. Boehringer Sohn, 6507 Ingelheim i-Phenoxy^-hydroxy-S-alklyaminopropane, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE1922003C3 (de) * 1969-04-30 1979-10-11 Boehringer Mannheim Gmbh, 6800 Mannheim N-(3-Aryloxy-2-hydroxypropyl)-aminocarbonsäuren, deren Ester, Amide und Salze, Verfahren zur Herstellung dieser Verbindungen und deren Verwendung bei der Bekämpfung von Herzinsuffizienz
US4220659A (en) * 1974-02-22 1980-09-02 Boehringer Ingelheim Gmbh 1-Phenoxy-2-hydroxy-3-alkynylamino-propanes and salts thereof
US4313889A (en) * 1975-09-22 1982-02-02 Merck & Co., Inc. Soft quaternary surface active agents
IT1116037B (it) * 1979-04-23 1986-02-10 Sigma Tau Ind Farmaceuti Esteri e ammidi di acil carnitine loro procedimenti di preparazione e loro uso terapeutico
US4405642A (en) * 1980-11-28 1983-09-20 American Hospital Supply Corporation Method for treatment or prophylaxis of cardiac disorders

Also Published As

Publication number Publication date
EP0065964B1 (en) 1985-10-23
EP0053436A1 (en) 1982-06-09
GR76922B (da) 1984-09-04
EP0065964A1 (en) 1982-12-08
PH18954A (en) 1985-11-26
IL64344A (en) 1985-11-29
AU547994B2 (en) 1985-11-14
ZA817891B (en) 1983-03-30
CA1180344A (en) 1985-01-02
WO1982001868A1 (en) 1982-06-10
EP0065964A4 (en) 1983-04-06
EP0053436B1 (en) 1986-03-12
DK336682A (da) 1982-07-28
JPS57502125A (da) 1982-12-02
KR830007512A (ko) 1983-10-21
DK163989B (da) 1992-04-27
US4405642A (en) 1983-09-20
KR880001828B1 (ko) 1988-09-20
NZ198871A (en) 1985-07-31

Similar Documents

Publication Publication Date Title
DK160314C (da) Analogifremgangsmaade til fremstilling af bicycliske pyrimidin-5-on-derivater og farmaceutisk acceptable salte deraf
DK165455C (da) Analogifremgangsmaade til fremstilling af dipeptidderivater og farmaceutisk acceptable salte heraf
DK157301C (da) Analogifremgangsmaade til fremstilling af hydantoinderivater og salte deraf
DK160940C (da) Analogifremgangsmaade til fremstilling af benzoheterocycliske forbindelser eller farmaceutisk acceptable salte deraf
DK164917C (da) Analogifremgangsmaade til fremstilling af bicyklisk substituerede dipeptidderivater og deres farmaceutisk acceptable salte
DK162444C (da) Analogifremgangsmaade til fremstilling af azabicyklooctancarboxylsyrer og farmaceutisk acceptable salte heraf
DK166381C (da) Analogifremgangsmaade til fremstilling af (3-aminopropoxy)-bibenzylderivater og farmaceutisk acceptable salte deraf
DK158269C (da) Analogifremgangsmaade til fremstilling af morpholinyldaunorubicin- eller morpholinyldoxorubicinderivater
DK152114C (da) Analogifremgangsmaade til fremstilling af propenylaminer eller farmaceutisk acceptable salte deraf
DK552581A (da) Fremgangsmaade til fremstilling af 3-pyridylaklyl-indol-forbindelser eller farmaceutisk acceptable salte deraf
DK161968C (da) Analogifremgangsmaade til fremstilling af imidazo-pyrazolo-pyrimidiner eller farmaceutisk acceptable salte deraf
DK163989C (da) Analogifremgangsmaade til fremstilling af beta-adrenergisk blokerende forbindelser og farmaceutisk acceptable salte deraf
DK149861C (da) Analogifremgangsmaade til fremstilling af s-adenosyl-methioninsalte
DK158306C (da) Analogifremgangsmaade til fremstilling af substituerede pyridylallylforbindelser eller farmaceutisk acceptable salte deraf
DK158658C (da) Analogifremgangsmaade til fremstilling af 9-aminoalkylfluorener eller farmaceutisk acceptable salte deraf
DK161699C (da) Analogifremgangsmaade til fremstilling af 4-aryl-4-piperidincarbinoler eller farmaceutisk acceptable salte deraf
DK152115C (da) Analogifremgangsmaade til fremstilling af fluorerede 2,5-diamino-3-pentenderivater og farmaceutisk acceptable salte deraf
DK85183D0 (da) Fremgangsmade til fremstilling af benzokondenserede tricycliske forbindelser eller farmaceutisk acceptable salte deraf og mellemprodukter derved
DK152491C (da) Analogifremgangsmaade til fremstilling af esterholdige phenoxypropanolaminer eller farmaceutisk anvendelige salte deraf
DK367683A (da) Fremgangsmaade til fremstilling af n-substituerede 1-oxido-nicotinamider og salte deraf
DK165983C (da) Fremgangsmaade til fremstilling af phosphorholdige antibiotiske forbindelser betegnet cl 1565-a, cl 1565-b og cl 1565-t eller farmaceutisk acceptable salte deraf
DK456483A (da) Fremgangsmaade til fremstilling af dichlorerede derivater af 16alfa-methylpregnanraekken
DK150521C (da) Analogifremgangsmaade til fremstilling af n2-arylsulfonyl-l-argininamider eller farmaceutisk acceptable salte deraf
DK423284D0 (da) Naphthalenylimidazopyridin og derivater heraf samt fremgangsmaade til fremstilling af saadanne forbindelser
DK149823C (da) Fremgangsmaade til fremstilling af kijanimicin eller farmaceutisk acceptable salte heraf